Integra Lifesciences Holdings (FRA:IL3) Accounts Payable & Accrued Expense : €87 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Accounts Payable & Accrued Expense?

Integra Lifesciences Holdings's quarterly accounts payable & accrued expense increased from Sep. 2023 (€172 Mil) to Dec. 2023 (€177 Mil) but then declined from Dec. 2023 (€177 Mil) to Mar. 2024 (€87 Mil).

Integra Lifesciences Holdings's annual accounts payable & accrued expense increased from Dec. 2021 (€161 Mil) to Dec. 2022 (€172 Mil) and increased from Dec. 2022 (€172 Mil) to Dec. 2023 (€177 Mil).

Integra Lifesciences Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Integra Lifesciences Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Accounts Payable & Accrued Expense Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

170.91

122.32

161.33

171.93

177.14

Integra Lifesciences Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															192.54	179.35	172.27	177.14	86.85

Integra Lifesciences Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Integra Lifesciences Holdings (FRA:IL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IART:USA

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines